Answer
Cemiplimab has a within-dosing-interval half-life of 22 days at steady state.
Sources for this answer
- LIBTAYO 350 mg concentrate for solution for infusion.Regeneron UK Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 25Document updated
Sources checked